Literature DB >> 32861016

Versatile hollow COF nanospheres via manipulating transferrin corona for precise glioma-targeted drug delivery.

Taotao Huo1, Yafeng Yang1, Min Qian1, Huiling Jiang1, Yilin Du1, Xiaoyi Zhang1, Yibo Xie1, Rongqin Huang2.   

Abstract

Covalent organic framework (COF) nanoparticles for interference-free targeted drug delivery to glioma remains in its infancy. Herein, hollow COF nanospheres with high crystallinity and uniformed sizes were facilely prepared via heterogeneous nucleation-growth. The prepared COF had large surface area/pore volume and exhibited appropriate degradation behavior under acid environment, where therefore doxorubicin was effectively encapsulated and exhibited a pH-sensitive release. Most charmingly, T10 peptide that has high affinity with transferrin (Tf), was conjugated to endow the hollow COF interesting properties to specifically absorb Tf in vivo as Tf corona. For the first time, multifunctional hollow COF nanospheres (the better one named DCPT-2) were successfully synthesized to achieve interference-free cascade-targeting glioma drug delivery across the blood-brain barrier. Treatment with DCPT-2 brought an improved therapeutic outcome with significantly prolonged median survival time and low side effects. This work promised not only a potential protein corona-mediated COF-based drug delivery platform with good biocompatibility for effective and precise brain tumor therapy, but also an endogenous protein corona-mediated targeting strategy for general cancer therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier (BBB); Covalent organic framework (COF); Glioma-targeted drug delivery; Transferrin corona

Mesh:

Substances:

Year:  2020        PMID: 32861016     DOI: 10.1016/j.biomaterials.2020.120305

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Transferrin-Enabled Blood-Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke.

Authors:  Qianqian Zhao; Wenxian Du; Lingling Zhou; Jianrong Wu; Xiaoxing Zhang; Xiaoer Wei; Sijia Wang; Yu Huang; Yuehua Li
Journal:  Pharmaceutics       Date:  2022-05-25       Impact factor: 6.525

2.  Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway.

Authors:  Yuanyuan Wu; Hongbing Wang; Dongdong Wei
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma.

Authors:  Lingling Wu; Qin Li; Junjie Deng; Jinglan Shen; Weide Xu; Wei Yang; Bingyu Chen; Yaoqiang Du; Wei Zhang; Feihang Ge; Siyun Lei; Kaiqiang Li; Zhen Wang
Journal:  Int J Nanomedicine       Date:  2021-12-29

4.  Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.

Authors:  Mengyu Chen; Yuexin Cui; Wenyan Hao; Yueyue Fan; Jingqiu Zhang; Qianqian Liu; Mingrui Jiang; Yang Yang; Yingzi Wang; Chunsheng Gao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ.

Authors:  Yimeng Du; Jing Gao; Hui Zhang; Xiaohui Meng; Dong Qiu; Xiang Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 6.  Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma.

Authors:  Maria João Ramalho; Joana Angélica Loureiro; Manuel A N Coelho; Maria Carmo Pereira
Journal:  Pharmaceutics       Date:  2022-01-25       Impact factor: 6.321

7.  Preparation of hollow tubular TpBD COF and pod-like ZIF-8/H-TpBD COF tubes using a porous anodic aluminum oxide membrane as template.

Authors:  Jiayuan He; Rijian Mo; Guangzheng Jiang; Lei He; Chunxia Zhou; Zhong-Ji Qian; Pengzhi Hong; Chengyong Li
Journal:  RSC Adv       Date:  2021-11-29       Impact factor: 3.361

Review 8.  Hollow structures as drug carriers: Recognition, response, and release.

Authors:  Decai Zhao; Nailiang Yang; Lekai Xu; Jiang Du; Yang Yang; Dan Wang
Journal:  Nano Res       Date:  2021-07-08       Impact factor: 8.897

9.  Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy.

Authors:  Liang Chen; Wenxing Wang; Jia Tian; Fanxing Bu; Tiancong Zhao; Minchao Liu; Runfeng Lin; Fan Zhang; Myongsoo Lee; Dongyuan Zhao; Xiaomin Li
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

10.  Tumor-Targeted Fluorescence Imaging and Mechanisms of Tumor Cell-Derived Carbon Nanodots.

Authors:  Taotao Huo; Wenshuai Li; Dong Liang; Rongqin Huang
Journal:  Pharmaceutics       Date:  2022-01-14       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.